United Kingdom· GB-APID-3931611000001107
Carisoma 125mg tablets
A carisoprodol product containing carisoprodol, registered in United Kingdom by Forest Laboratories UK Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Carisoprodol is registered in 3 of 19 countries.
Countries holding a registration under ATC M03BA02 (carisoprodol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 2 of them publish a price we can compare per daily dose
Carisoprodol · ATC M03BA02
3 / 19 countries
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carisoprodol costs, country by country.
Normalised to the WHO defined daily dose (1.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carisoprodol · price per daily dose (1.4 g)
USD · FX 28 Sept 2026
- US United States$0.28 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Carisoprodol
- Manufacturer
- Forest Laboratories UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- M03BA02
- ATC class
- Carisoprodol
- Defined daily dose
- 1.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
214 interactions on record for carisoprodol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carisoprodol · interactions on record
214 records
- 4 severe
- 67 moderate
- 2 minor
- 141 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carisoprodol in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b840bdb3-e600-44ca-bc21-3e0a6c3f6173 GET /v1/drugs/b840bdb3-e600-44ca-bc21-3e0a6c3f6173?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3931611000001107",
"desc": "Carisoma 125mg tablets (Forest Laboratories UK Ltd)",
"form": "Oral tablet",
"vpid": "42100211000001100",
"source": "dmd",
"vtm_id": "775071003",
"strength": "125 mg",
"substance": "Carisoprodol",
"ingredient": "Carisoprodol",
"supplier_code": "2082801000001107"
}See everything about carisoprodol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.